CARMA3/NF-κB signaling contributes to tumorigenesis of hepatocellular carcinoma and is inhibited by sodium aescinate

被引:0
作者
Hui Hou [1 ]
Wei-Xiang Li [1 ]
Xiao Cui [1 ,2 ]
Da-Chen Zhou [1 ]
Bin Zhang [1 ]
Xiao-Ping Geng [1 ,3 ]
机构
[1] Department of General Surgery, The Second Hospital of Anhui Medical University
[2] Department of Surgery, University of Pittsburgh
[3] Department of Hepatobiliary Surgery, The First Affiliated Hospital of Anhui Medical University
关键词
CARMA3; Nuclear factor kappa-B; Sodium aescinate; Hepatocellular carcinoma; Tumorigenesis; Liver cancer;
D O I
暂无
中图分类号
R735.7 [肝肿瘤];
学科分类号
100214 ;
摘要
BACKGROUND Primary hepatocellular carcinoma(HCC) is a very malignant tumor in the world.CARMA3 plays an oncogenic role in the pathogenesis of various tumors.However, the function of CARMA3 in HCC has not been fully clarified.AIM To study the biological function of CAEMA3 in HCC.METHODS Tissue microarray slides including tissues form 100 HCC patients were applied to access the expression of CARMA3 in HCC and its clinical relevance. Knockdown and overexpression of CARMA3 were conducted with plasmid transfection.MTT, colony formation, and apoptosis assays were performed to check the biological activity of cells.RESULTS Higher expression of CARMA3 in HCC was relevant to poor prognostic survival(P < 0.05). Down-regulation of CARMA3 inhibited proliferation and colony formation and induced apoptosis in HCC cell lines, while increasing its expression promoted tumorigenesis. We also found that sodium aescinate(SA), a natural herb extract, exerted anti-proliferation effects in HCC cells by suppressing the CARMA3/nuclear factor kappa-B(NF-κB) pathway.CONCLUSION Overexpression of CARMA3 in HCC tissues correlates with a poor prognosis in HCC patients. CARMA3 acts pro-tumorigenic effects partly through activation of CARMA3/NF-κB. SA inhibits HCC growth by targeting CARMA3/NF-κB.
引用
收藏
页码:5483 / 5493
页数:11
相关论文
共 7 条
[1]  
The effects of IKK-beta inhibition on early NF-kappa-B activation and transcription of downstream genes[J] . Meghan J. Bloom,Sachit D. Saksena,George P. Swain,Marcelo S. Behar,Thomas E. Yankeelov,Anna G. Sorace. Cellular Signalling . 2018
[2]  
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J] . Freddie Bray BSc,MSc,PhD,Jacques Ferlay ME,Isabelle Soerjomataram MD,MSc,PhD,Rebecca L. Siegel MPH,Lindsey A. Torre MSPH,Ahmedin Jemal PhD,DVM. CA: A Cancer Journal for Clinicians . 2018 (6)
[3]  
Molecular targets and anti-cancer potential of escin[J] . Dorothy H.J. Cheong,Frank Arfuso,Gautam Sethi,Lingzhi Wang,Kam Man Hui,Alan Prem Kumar,Thai Tran. Cancer Letters . 2018
[4]  
Hepatocellular carcinoma[J] . Alejandro Forner,María Reig,Jordi Bruix. The Lancet . 2018 (1012)
[5]  
The CARMA3–Bcl10–MALT1 Signalosome Drives NFκB Activation and Promotes Aggressiveness in Angiotensin II Receptor–Positive Breast Cancer[J] . Prasanna Ekambaram,Jia-Ying (Lloyd) Lee,Nathaniel E. Hubel,Dong Hu,Saigopalakrishna Yerneni,Phil G. Campbell,Netanya Pollock,Linda R. Klei,Vincent J. Concel,Phillip C. Delekta,Arul M. Chinnaiyan,Scott A. Tomlins,Daniel R. Rhodes,Nolan Priedigkeit,Adrian V. Lee,Steffi Oesterreich,Linda M. McAllister-Lucas,Peter C. Lucas. Cancer Research . 2018
[6]  
CARMA3 is a host factor regulating the balance of inflammatory and antiviral responses against viral infection[J] . Changying Jiang,Zhicheng Zhou,Yanping Quan,Shilei Zhang,Tingting Wang,Xueqiang Zhao,Clayton Morrison,Mark T. Heise,Wenqian He,Matthew S. Miller,Xin Lin. Cell Reports . 2016
[7]  
The Three CARMA Sisters: So Different, So Similar: A Portrait of the Three CARMA Proteins and Their Involvement in Human Disorders[J] . Ivan Scudiero,Pasquale Vito,Romania Stilo. J. Cell. Physiol. . 2014 (8)